WHO ICTRP trial

A multicenter, randomized, double-blind, placebo-controlled trial for Tanreqing…

ITMCTR2000003143 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting

Key facts

Trial ID ITMCTR2000003143
Public title A multicenter, randomized, double-blind, placebo-controlled trial for Tanreqing capsule in the treatment of acute exacerbation of mild to moderate COPD
Scientific title A multicenter, randomized, double-blind, placebo-controlled trial for Tanreqing capsule in the treatment of acute exacerbation of mild to moderate COPD
Primary sponsor Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Chronic obstructive pulmonary disease
Interventions control group:Basic treatment of Western medicine, plus 3 placebo capsules, 3 times a day, oral;Experimental group A:Western medicine basic treatment, plus three Tanreqing capsules, three times a day, oral.;Experimental group B:Western…
Registration date Mar 21, 2020
Target size control group:80;Experimental group A:80;Experimental group B:80
Secondary IDs ChiCTR2000031080;ChiMCTR2000003143
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations